Erratum: Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience (Catheterization and Cardiovascular Interventions (2014) 77 (700-706) DOI: 10.1002/ccd.22764);Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation: Initial European experience

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 5, 2011, Pages 700-706

  Park, Jai Wun ^a   Bethencourt, Armando ^b   Sievert, Horst ^c   Santoro, Gennaro ^d   Meier, Bernhard ^e   Walsh, Kevin ^f   Lopez Minquez, Jose Ramon ^g   Meerkin, David ^h   Valdés, Mariano ⁱ   Ormerod, Oliver ^j   Leithäuser, Boris ^a  

^a Asklepios Klinik Harburg   (Germany)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c CardioVascular Center Frankfurt Sankt Katharinen   (Germany)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF BERN   (Switzerland)

^f Mater Private Hospitals   (Ireland)

^g HOSPITAL INFANTA CRISTINA   (Spain)

^h SHAARE ZEDEK MEDICAL CENTER   (Israel)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^j JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

atrial appendage; atrial fibrillation; prosthesis and implants; stroke; thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ISCHEMIA; DEVICE EMBOLIZATION; DEVICE REMOVAL; DEVICE SAFETY; DEVICE THERAPY; FEASIBILITY STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HEART LEFT ATRIAL APPENDAGE OCCLUSION; HEART MUSCLE ISCHEMIA; HUMAN; IATROGENIC DISEASE; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; RETROSPECTIVE STUDY; SEPTAL OCCLUDER;

EID: 79953040948     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25619     Document Type: Erratum

References (48)

1. Falk RH,. Atrial fibrillation. N Engl J Med 2001; 344: 1067-1078. (Pubitemid 32267978)
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375. (Pubitemid 32424106)
3. Kannel WB, Benjamin EJ,. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008; 92: 17-40, ix. (Pubitemid 350182405)
4. Lloyd-Jones D, Adams R, Carnethon M, de Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y,. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-e181.
5. Walker AM, Bennett D,. Epidemiology and outcomes in patients with atrial fibrillation in the United States. Heart Rhythm 2008; 5: 1365-1372.
6. Hart RG, Aguilar MI,. Anticoagulation in atrial fibrillation: Selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage. J Thromb Thrombolysis 2008; 25: 26-32.
7. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS,. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009; 151: 297-305.
8. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT,. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000; 160: 41-46. (Pubitemid 30040971)
9. Peterson GM, Boom K, Jackson SL, Vial JH,. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: Identifying barriers to stroke prevention. Intern Med J 2002; 32: 15-23. (Pubitemid 36124632)
10. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B,. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175-179. (Pubitemid 19038801)
11. Hylek EM, D'Antonio J, Evans-Molina C, Shea C, Henault LE, Regan S,. Translating the results of randomized trials into clinical practice: The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke 2006; 37: 1075-1080.
12. Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ,. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Thromb Res 2007; 120: 663-669. (Pubitemid 47271911)
13. Srivastava A, Hudson M, Hamoud I, Cavalcante J, Pai C, Kaatz S,. Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy. Thromb J 2008; 6: 6.
14. Baker WL, Cios DA, Sander SD, Coleman CI,. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm 2009; 15: 244-252.
15. Man-Son-Hing M, Laupacis A,. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation. Arch Intern Med 2002; 162: 541-550. (Pubitemid 34193541)
16. Poli D, Antonucci E, Marcucci R, Fatini C, Alterini B, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D,. Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score. Thromb Res 2007; 121: 347-352.
17. Hylek EM,. Antithrombotic prophylaxis in elderly patients with atrial fibrillation. Semin Thromb Hemost 2009; 35: 548-553.
18. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE,. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999; 131: 927-934. (Pubitemid 30005032)
19. Protheroe J, Fahey T, Montgomery AA, Peters TJ,. The impact of patients' preferences on the treatment of atrial fibrillation: Observational study of patient based decision analysis. BMJ 2000; 320: 1380-1384. (Pubitemid 30261119)
20. Gattellari M, Worthington J, Zwar N, Middleton S,. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: A representative survey of Australian family physicians. Stroke 2008; 39: 227-230.
21. Aberg H,. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969; 185: 373-379.
22. Stoddard MF, Dawkins PR, Prince CR, Ammash NM,. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25: 452-459.
23. Blackshear JL, Odell JA,. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-759. (Pubitemid 26060923)
24. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, Johnson RG, Douglas PS,. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995; 123: 817-822.
25. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF,. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994; 24: 755-762. (Pubitemid 24295753)
26. Odell JA, Blackshear JL, Davies E, Byrne WJ, Kollmorgen CF, Edwards WD, Orszulak TA,. Thoracoscopic obliteration of the left atrial appendage: Potential for stroke reduction? Ann Thorac Surg 1996; 61: 565-569. (Pubitemid 26060882)
27. Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M,. The left atrial appendage: Our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 2000; 17: 718-722. (Pubitemid 30364952)
28. Halperin JL, Gomberg-Maitland M,. Obliteration of the left atrial appendage for prevention of thromboembolism. J Am Coll Cardiol 2003; 42: 1259-1261. (Pubitemid 37203397)
29. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B,. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-e231. (Pubitemid 44268973)
30. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ,. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005; 150: 288-293. (Pubitemid 41116255)
31. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della BP, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D,. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002; 105: 1887-1889. (Pubitemid 34437613)
32. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM,. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-422. (Pubitemid 37356515)
33. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR,. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007; 49: 1490-1495. (Pubitemid 46505070)
34. Onalan O, Crystal E,. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 2007; 38: 624-630. (Pubitemid 46184230)
35. Syed TM, Halperin JL,. Left atrial appendage closure for stroke prevention in atrial fibrillation: State of the art and current challenges. Nat Clin Pract Cardiovasc Med 2007; 4: 428-435. (Pubitemid 47180327)
36. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P,. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009; 374: 534-542.
37. Leithäuser B, Broemel T, Park JW,. Left atrial appendage closure with Amplatzer Cardiac Plug for prevention of stroke in atrial fibrillation: In-vivo imaging. J Cardiovasc Med (Hagerstown), doi: 10.2459/JCM. 0b013e32833a09ef.
38. Al Saady NM, Obel OA, Camm AJ,. Left atrial appendage: Structure, function, and role in thromboembolism. Heart 1999; 82: 547-554. (Pubitemid 29515446)
39. Leithäuser B, Park JW,. Cardioembolic stroke in atrial fibrillation-Rationale for preventive closure of the left atrial appendage. Korean Circ J 2009; 39: 443-458.
40. Choudhury A, Lip GY,. Atrial fibrillation and the hypercoagulable state: From basic science to clinical practice. Pathophysiol Haemost Thromb 2003; 33: 282-289. (Pubitemid 40278696)
41. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L,. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
42. Hoit BD, Shao Y, Tsai LM, Patel R, Gabel M, Walsh RA,. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 1993; 72: 167-175.
43. Davis CA III, Rembert JC, Greenfield JC Jr,. Compliance of left atrium with and without left atrium appendage. Am J Physiol 1990; 259: H1006-H1008. (Pubitemid 20352295)
44. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. (Pubitemid 32537350)
45. Holmes DR Jr, Schwartz RS,. Left atrial appendage occlusion eliminates the need for warfarin. Circulation 2009; 120: 1919-1926.
46. Whitlock RP, Healey JS, Connolly SJ,. Left atrial appendage occlusion does not eliminate the need for warfarin. Circulation 2009; 120: 1927-1932.
47. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651-745. (Pubitemid 44472247)
48. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E,. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study. BAFTA): A randomised controlled trial. Lancet 2007; 370: 493-503. (Pubitemid 47212371)